Pharmagreen Biotech Stock Today
| PHBI Stock | USD 0 0.0001 5.88% |
Performance10 of 100
| Odds Of DistressLess than 26
|
Pharmagreen Biotech is trading at 0.0018 as of the 1st of December 2024. This is a 5.88 percent increase since the beginning of the trading day. The stock's open price was 0.0017. Pharmagreen Biotech has about a 26 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat ok performance during the last 90 days. Equity ratings for Pharmagreen Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2023 and ending today, the 1st of December 2024. Click here to learn more.
Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada. Pharmagreen Biotech is traded on OTC Exchange in the United States.. The company has 454.76 M outstanding shares. More on Pharmagreen Biotech
Moving against Pharmagreen Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pharmagreen Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Pharmagreen Biotech [PHBI] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.96 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharmagreen Biotech's market, we take the total number of its shares issued and multiply it by Pharmagreen Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pharmagreen Biotech conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 454.76 M outstanding shares.
Pharmagreen Biotech currently holds about 24.26 K in cash with (426.57 K) of positive cash flow from operations.
Check Pharmagreen Biotech Probability Of Bankruptcy
Ownership AllocationPharmagreen Biotech owns a total of 454.76 Million outstanding shares. Pharmagreen Biotech holds 18.63 pct. of its outstanding shares held by insiders and 0.0 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Pharmagreen Ownership Details
Pharmagreen Biotech Risk Profiles
| Mean Deviation | 10.47 | |||
| Semi Deviation | 10.23 | |||
| Standard Deviation | 13.61 | |||
| Variance | 185.32 |
Pharmagreen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pharmagreen Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Other Information on Investing in Pharmagreen Pink Sheet
Pharmagreen Biotech financial ratios help investors to determine whether Pharmagreen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmagreen with respect to the benefits of owning Pharmagreen Biotech security.